Comparing the Safety Profiles of two NaPi2b ADCs Produced using Different Platforms
Time: 9:00 am
day: Conference Day 1
Details:
- Optimizing an ADC platform to minimize platform off-target toxicity
- Comparing two NaPi2b ADCs produced using two different platforms, improving safety and efficacy both pre-clinically and clinically
- Leveraging the rat versus NHPs, for investigative mechanistic studies